TGF-β regulation of osteoblast diferentiation and bone matrix properties

Journal of Musculoskeletal Neuronal Interactions

Volumn 6, Issue 4, 2006, Pages 349-350

  Alliston, Tamara N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone matrix material properties; Hearing loss; Runx2; TGF beta

Indexed keywords

HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; BONE DEFECT; BONE MATRIX; BONE MINERAL; CELL DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; HEARING LOSS; HUMAN; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PAGET BONE DISEASE; PERCEPTION DEAFNESS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BONE DISEASES; BONE MATRIX; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HEARING LOSS; HUMANS; MICE; OSTEOBLASTS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846256135     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Currey JD. What determines the bending strength of compact bone? J Exp Biol 1999; 202(Pt 18):2495-2503.
2. Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ. Both hPTH(I-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. J Bone Miner Res 2003; 18:2105-2115.
3. Poli V, Balena R, Fattori E, Markatos A, Yamomoto M, Tanaka H, Ciliberto G, Rodan GA, Constantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13:1189-1196.
4. Misof K, Landis WJ, Klaushofer K, Fratzl P. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest 1997; 100:40-45.
5. Balooch G, Balooch M, Nalla RK, Schilling S, Filvaroff EH, Marshall GW, Marshall SJ, Ritchie RO, Derynck R, Alliston T. TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci USA 2005; 102:18813-18818.
6. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfal and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001; 20:2254-2272.
7. Kang JS, Alliston T, Delston R, Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J 2005; 24:2543-2555.
8. Borton AJ, Frederick JP, Datto MB, Wang XF, Weinstein RS. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res 2001; 16:1754-1764.
9. Yang X, Chen L, Xu X, Li C, Huang C, Deng CX TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 2001; 153:35-46.
10. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004; 119:555-566.
11. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen Br, Selby PB, Owen MJ. Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89:765-771.
12. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosislike phenotype. J Cell Biol 1996; 132:195-210.
13. Komori T, Yagi H, Nomura S, Yamahuchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfat results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89:755-764.
14. Monsell EM. The mechanism of hearing loss in Paget's disease of bone. Laryngoscope 2004; 114:598-606.
15. Visosky AM, Johnson J, Bingea B, Gurney T, Lalwani AK. Otolaryngological manifestations of cleidocranial dysplasia, concentrating on audiological findings. Laryngoscope 2003; 113:1508-1514.
16. Cooper SC, Flaitz CM, Johnston DA, Lee B, Hecht JT. A natural history of cleidocranial dysplasia. Am J Med Genet 2001; 104:1-6.
17. Higashi K, Matsuki C. Hearing impairment in Engelmann disease. Am J Otol 1996; 17:26-29.
18. Hartikka H, Kuurila Y, Korkko J, Kaitila I, Grenman R, Pynnonen S, Hyland JC, Ala-Kokko L. Lack of correlation between the type of COLIA1 or COLIA2 mutation and hearing loss in osteogenesis imperfecta patients. Hum Mutat 2004 24:147-154.
19. Chole RA, McKenna M. Pathophysiology of otosclerosis. Otol Neurotol 2001; 22:249-257.